Atossa Therapeutics ATOS
NASDAQ ATOS
$2.34 +0.07 (+3.08%)
At close: Oct 2, 2026 · 4:00 PM EDT

Atossa Therapeutics (ATOS) Income from Discontinued Operations (2015)

Updated

Atossa Therapeutics (ATOS) posted Income from Discontinued Operations of -$2.37 million for Q4 2015.

Analysis

Atossa Therapeutics (ATOS) Income from Discontinued Operations (2015) Analysis & Trends

For FY2015, Atossa Therapeutics' Income from Discontinued Operations came in at -$3 million.

  • In prior years, Atossa Therapeutics' Income from Discontinued Operations was -$2.49 million in FY2014.
  • According to Business Quant data, Income from Discontinued Operations for the three prior quarters was -$544,802 (Q3 2015), -$23,438 (Q2 2015) and -$61,204 (Q1 2015).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 8.00 Mn
10 Atossa Therapeutics 23.35 Mn 23.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 -2.37 Mn
Sep 30, 2015 -544,802.00
Jun 30, 2015 -23,438.00
Mar 31, 2015 -61,204.00
API Access

Atossa Therapeutics Income from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=ATOS&period=max&api_key=YOUR_API_KEY